Supplement industry news and updates – July 2024

DOJ faces ‘capacity’ litigating dietary supplement cases – article

Trade groups representing manufacturers and retailers of dietary supplement products often call on the U.S. Department of Justice (DOJ) to vigorously enforce against “bad actors,” but a DOJ trial attorney emphasized that bringing cases in the dietary supplement sphere is challenging and often involves “deep science,” underscoring the need for clarity. Read more here.

7 marketing insights to succeed in the mature women’s market – article

Developing and bringing to market supplement products for the modern adult women’s wellness segment requires a nuanced approach in brand marketing, positioning and package design. Read on and consider these priorities to make an impact in this high-growth area here.

Does contract manufacturing raise the bar on science-driven quality? – video

Contract and private label supplement manufacturers carry responsibility for quality product creation and hold the power to elevate industry standards, impact product quality and influence consumer trust. We spoke with Premier Research Labs about their industry-leading approach. Product brand holders need to vet their contract manufacturers and link their brand to trusted partners in quality. Read more here.

NBJ Market View: How 30 industry insiders would change DSHEA – article      

As the landmark legislation turns 30, learn what 30 supplement industry insiders — doctors, lawyers, marketers and more — would do to improve the Dietary Supplement Health and Education Act. See what they would change after three decades of scientific research and regulatory battles and the industry-altering rise of internet marketing. Read more here.

Have we reached peak gummy? – analysis

With gummy product launches slowing and shelves brimming with potentially overwhelming options, NBJ Senior Analyst Erika Craft ponders what’s next for the chewy format. In 2023, NBJ predicted gummies to be the second-highest growth format, at 8.7%, only slightly tapering off in 2025 to 8%, but it’s wise to see what other formats are performing well and where product development opportunities lie. Read more here.

Kratom: Marketplace is ‘completely ignoring what FDA is saying’ about kratom – article

The nation’s top FDA official responsible for enforcing dietary supplement product regulations said she is frustrated with the years-long trend. FDA is “explicitly clear on our position… and we still regularly find it (kratom in supplements),” said Cara Welch, Ph.D., director of FDA’s Office of Dietary Supplement Programs (ODSP). Read more about this regulatory challenge here.

Understanding and embracing the power of all data in clinical research and why that matters – article

Radicle Science co-founders Pelin Thorogood and Jeff Chen, M.D. discuss how to evaluate what is “good science” considering the complexities of real-world conditions and what consumers can reasonably expect from their supplements — which, by design and regulations, are created to optimize health versus cure disease states. What key data points should formulators and product developers consider when creating products that deliver benefits that consumers desire? Read on here.